Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-01-22
1994-03-29
Friedman, S. J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3140
Patent
active
052985229
ABSTRACT:
A method of producing analgesia and treating antiinflammatory disease in a human subject while avoiding proteinuria by administering 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide or a pharmaceutically-acceptable base salt thereof.
REFERENCES:
patent: 4556672 (1985-12-01), Kadin
patent: 4569942 (1986-02-01), Kadin
patent: 4658037 (1987-04-01), Kadin
patent: 4853409 (1989-08-01), Showell
patent: 4861794 (1989-08-01), Otterness
patent: 5047554 (1991-09-01), Ehrgott
Cooper Kelvin
Littman Bruce H.
Pazoles Christopher J.
Wilner Keith D.
Benson Gregg C.
Brokke Mervin E.
Friedman S. J.
Pfizer Inc.
Richardson Peter C.
LandOfFree
6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-792149